NT
NK-One Therapeutics, Inc.
SEC filingBiotechnology · Wayne, PA
Amount raised$290Ksold at filing
Total offering$310K$20K still open
Investors in the raise7count reported to the SEC
FiledApr 27, 2026first sale Mar 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Marco PappagalloExecutive Officer, Director
Michael ShineExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.